Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study

Expression of proliferating cell nuclear

Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: An immunochemical study with clinical, pathobiological, and histologic correlations

✍ Giuseppe Pelosi; Enrica Bresaola; Stefania Rodella; Erminia Manfrin; Quirino Piu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 913 KB

Sixty-six unselected breast cancers were analyzed in cytologic smears and histologic sections for the expression of proliferating cell nuclear antigen (PCNA), estrogen receptor protein (ERP), and p53 protein using a standard immunochemical method. The results, expressed as both positive cases and la